Hop til indholdet
Tilbage
  • Frontpage
  • Our services
    • Project management
    • Synthesis
    • Analytical
    • Pilot plant
    • Quality assurance
  • About us
    • The NCK story so far
    • Core business
    • Business with NCK
    • Meet our team
    • Mission, Vision & Values
    • CSR strategy
  • Downloads
  • Contact us
  • File share login

Core business

NCK’s core business is Synthetic Organic Chemistry

Cutting edge process

NCK provides cutting edge process development and API manufacturing (e.g. process development, analytical development, reference samples, supply of API for toxicology and human studies, API release, ICH stability studies as well as relevant progress reports and GMP documentation) for biotech and pharma companies who want to take NCEs from discovery to commercialization.

NCK offers all relevant services for fulfilling regulatory requirements when applying for an IND / IMPD. NCK is built on the foundation of synthetic organic chemistry, and we have seen and have been involved in most of the latest innovative chemistry.

Global
presence

USA

Davos Pharma
600 East Cresent Avenue
Upper Staddle River
New Jersey 07458
+1 201.995.0070

www.davos.com

info@davos.com

Japan

Chukan Butsu Ltd
7th Floor, Shiono Nissei Building
6-6, 2-Chome, Doshomachi
Chuo-Ku, Osaka, 541-0045
+81 06 6231 5127

www.chukan.co.jp

info@chukan.co.jp

Israel

Aneeva Ltd.
Emek Hahula 31
Modiin
+972 77 515 5025

www.aneeva.com

nck@aneeva.com

Get in
touch

Contact information

NCK A/S
Rugmarken 28
DK 3520 Farum
Denmark

CVR: 89797519

Phone: +45 4495 1881
Email: nck@nck.dk
Email for unsolicited applications: hr@nck.dk

Follow us on Linkedin

Our services
  • Project management
  • Synthesis
  • Analytical laboratory
  • Pilot plant
  • Quality assurance
About NCK
  • The NCK story so far
  • Core business
  • Business with NCK
  • Meet our team
  • Mission, Vision & Values
  • CSR strategy
  • Terms & Conditions
Useful links
  • Digital brochure
  • General terms and conditions
  • GMP Certificate 2020